Home >> Marketplace Archives >> BD launches TB test in Europe

BD launches TB test in Europe

Print Friendly, PDF & Email

December 2018—BD announced the availability of the CE-marked BD Max MDR-TB panel in Europe. Clinicians can use the single PCR-based molecular diagnostic test to simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain mutations associated with resistance to two first-line drugs, isoniazid and rifampicin.

BD, 201-847-6800

X